Pharmaceutical Company Setup in Pakistan

The pharmaceutical sector is one of the most tightly regulated areas of business anywhere, and Pakistan is no exception. Because medicines directly affect human health and life, every stage, manufacturing, importing, registering, marketing, and selling drugs, is subject to detailed licensing and oversight. Establishing a pharmaceutical business therefore involves far more than incorporating a company; it requires handling a specialised regulatory regime from the outset. Global Law Company advises manufacturers, importers, distributors, and investors across Pakistan on setting up pharmaceutical businesses and meeting the regulatory requirements that govern them.

Getting the regulatory foundations right is essential in this sector, because a misstep can mean refused registrations, seized products, or suspended licences, outcomes that can be fatal to a pharmaceutical business. We help clients build the business correctly, anticipate the regulator's requirements, and stay compliant as they grow.

The regulatory framework for pharmaceuticals

Pharmaceuticals in Pakistan are regulated principally by the Drug Regulatory Authority of Pakistan (DRAP) under the DRAP Act 2012 and the Drugs Act 1976, together with the rules made under them governing licensing, registration, pricing, labelling, and good manufacturing practice. A pharmaceutical business is incorporated with SECP under the Companies Act 2017, but its ability to operate depends on DRAP authorisations: a drug manufacturing licence for producers, registration of each drug or product, and import authorisations for those bringing medicines into the country. Pricing of medicines is regulated, manufacturing must meet good-manufacturing-practice standards, and marketing and distribution are subject to their own controls.

Manufacturing licences and good manufacturing practice

For a manufacturer, the central requirement is the drug manufacturing licence, which DRAP grants only where the facility, equipment, personnel, and systems meet the prescribed standards, including good manufacturing practice (GMP). We advise prospective manufacturers on the requirements for the licence, on structuring the facility and quality systems to meet GMP, and on assembling and presenting the application to DRAP. Because the standards are exacting and inspections rigorous, preparing properly for licensing and for the inspections that follow is critical to obtaining and keeping the licence.

Drug registration, import, and pricing

Every drug must be registered before it can be marketed, and registration involves demonstrating the product's quality, safety, and efficacy through the dossier DRAP requires. We advise on the registration of locally manufactured and imported drugs, on the import authorisations and arrangements with foreign principals that importers need, and on the regulated pricing regime that governs how medicines may be priced and any price increases sought. We help clients manage the registration and pricing processes, which are often the longest and most consequential steps in bringing a product to market.

Distribution, marketing, and ongoing compliance

Beyond manufacturing and registration, pharmaceutical businesses must comply with the rules governing the distribution, storage, labelling, and marketing of medicines, including controls on the promotion of drugs and the licensing of those who distribute and sell them. We advise on distribution and agency arrangements, on labelling and packaging compliance, and on the marketing controls that apply to prescription and other medicines. We also support pharmaceutical businesses through DRAP inspections, regulatory queries, and any enforcement matters, and we advise on the handling of product-quality issues and recalls, which require both regulatory and reputational care.

Medical devices, supplements, and allied products

The regulatory framework reaches beyond conventional medicines. Medical devices, therapeutic and nutritional supplements, biologicals, and allied health products each fall within DRAP's expanding remit and carry their own classification, registration, and import requirements. Businesses in these adjacent areas often assume they fall outside drug regulation, only to discover that their products require DRAP authorisation. We advise manufacturers, importers, and distributors of medical devices, supplements, and related products on how their products are classified and regulated, on the registrations and approvals they require, and on labelling and marketing compliance, so they enter the market lawfully rather than risking seizure or enforcement.

Contracts, licensing, and partnerships

Pharmaceutical businesses run on a network of contracts and partnerships, toll-manufacturing and contract-manufacturing agreements, licensing and distribution agreements with local and multinational principals, supply agreements for active ingredients, and clinical and research collaborations. We draft and negotiate these agreements with attention to the regulatory conditions that govern them, including the responsibilities of each party for registration, quality, and pharmacovigilance, and the intellectual-property and exclusivity terms that drive value in the sector. Well-structured contracts let pharmaceutical businesses partner and expand while keeping regulatory responsibility and commercial risk clearly allocated.

How Global Law Company helps

We act for pharmaceutical businesses from incorporation and licensing through registration, import, distribution, and ongoing compliance. Because the sector is defined by its regulation, our value lies in guiding clients through DRAP's requirements efficiently and building a compliance culture that protects the licences the business depends on. We combine corporate, regulatory, and commercial capability, so we can take a sponsor from concept to a licensed, product-registered pharmaceutical business and support it as it expands its portfolio.

Why choose Global Law Company

Pharmaceutical work rewards advisers who understand the DRAP framework and the stakes of compliance, and clients value that we bring both. We prepare licensing and registration applications that meet the standard, structure manufacturing and import operations to satisfy the regulator, and keep clients ahead of the pricing, labelling, and marketing rules that govern the sector. For a business where regulation is the licence to operate, that focus is exactly what is needed.

Talk to us about setting up a pharmaceutical company in Pakistan